US Stock MarketDetailed Quotes

HQL abrdn Life Sciences Investors

Watchlist
  • 13.480
  • -0.050-0.37%
Close Jan 17 16:00 ET
  • 13.480
  • 0.0000.00%
Post 20:01 ET
353.34MMarket Cap134.80P/E (TTM)

abrdn Life Sciences Investors Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q2)Mar 31, 2024
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q2)Mar 31, 2023
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q2)Mar 31, 2022
(FY)Sep 30, 2021
Assets
Cash cash equivalents and federal funds sold
-99.79%1
-99.79%1
----
7.19%477
7.19%477
-99.72%822
-55.05%445
--445
183,800.63%292.4K
--990
-Cash and cash equivalents
-99.79%1
-99.79%1
----
7.19%477
7.19%477
-99.72%822
-55.05%445
--445
183,800.63%292.4K
--990
Receivables
-95.42%231.11K
-95.42%231.11K
759.17%110.13K
709.12%5.04M
709.12%5.04M
-99.59%12.82K
333.95%623.47K
--623.47K
57,197.26%3.1M
94.42%143.67K
Prepaid assets
59.18%41.53K
59.18%41.53K
50.60%49.99K
3.63%26.09K
3.63%26.09K
3.87%33.19K
-4.27%25.18K
--25.18K
-27.06%31.95K
-2.43%26.3K
-Available for sale securities
--17.23M
--17.23M
15.55%13.84M
----
----
--11.98M
----
----
----
----
Other assets
0.00%189
0.00%189
1,400.53%2.84K
0.00%189
0.00%189
-91.42%189
-97.17%189
--189
-97.26%2.2K
-92.73%6.67K
Total assets
14.40%460.58M
14.40%460.58M
2.14%441.95M
-2.92%402.6M
-2.92%402.6M
-3.51%432.69M
-22.36%414.73M
--414.73M
-10.91%448.41M
10.33%534.19M
Liabilities
Payables
--470.23K
--470.23K
-92.87%665.12K
----
----
-22.36%9.33M
86.11%16.19M
--16.19M
27,169.06%12.02M
62,297.12%8.7M
-Accounts payable
--1.79K
--1.79K
--229.3K
----
----
----
--5.1M
--5.1M
7,935.07%3.54M
----
-Other payable
--468.44K
--468.44K
-95.33%435.82K
----
----
10.07%9.33M
27.49%11.09M
--11.09M
--8.48M
62,297.12%8.7M
Derivative product liabilities
--50.81K
--50.81K
----
----
----
----
----
----
--209.84K
11,002.51%1.34M
Total liabilities
33.23%888.61K
33.23%888.61K
-91.24%879.91K
-96.04%666.96K
-96.04%666.96K
-22.36%10.04M
56.56%16.82M
--16.82M
1,891.35%12.94M
1,705.34%10.75M
Shareholders'equity
Share capital
4.74%280.61K
4.74%280.61K
4.34%273.51K
4.33%267.91K
4.33%267.91K
4.25%262.12K
4.10%256.8K
--256.8K
3.56%251.44K
3.29%246.68K
-common stock
4.74%280.61K
4.74%280.61K
4.34%273.51K
4.33%267.91K
4.33%267.91K
4.25%262.12K
4.10%256.8K
--256.8K
3.56%251.44K
3.29%246.68K
Paid-in capital
3.01%415.29M
3.01%415.29M
3.81%410.6M
3.88%403.15M
3.88%403.15M
3.85%395.55M
4.19%388.1M
--388.1M
4.57%380.89M
4.54%372.49M
Retained earnings
3,079.17%44.13M
3,079.17%44.13M
12.52%30.19M
-115.51%-1.48M
-115.51%-1.48M
-50.62%26.83M
-93.66%9.55M
--9.55M
-60.68%54.34M
18.63%150.7M
Total stockholders'equity
14.37%459.69M
14.37%459.69M
4.36%441.07M
1.01%401.93M
1.01%401.93M
-2.95%422.65M
-23.98%397.9M
--397.9M
-13.37%435.47M
8.24%523.44M
Total equity
14.37%459.69M
14.37%459.69M
4.36%441.07M
1.01%401.93M
1.01%401.93M
-2.95%422.65M
-23.98%397.9M
--397.9M
-13.37%435.47M
8.24%523.44M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Unqualified Opinion
(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q2)Mar 31, 2024(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q2)Mar 31, 2023(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q2)Mar 31, 2022(FY)Sep 30, 2021
Assets
Cash cash equivalents and federal funds sold -99.79%1-99.79%1----7.19%4777.19%477-99.72%822-55.05%445--445183,800.63%292.4K--990
-Cash and cash equivalents -99.79%1-99.79%1----7.19%4777.19%477-99.72%822-55.05%445--445183,800.63%292.4K--990
Receivables -95.42%231.11K-95.42%231.11K759.17%110.13K709.12%5.04M709.12%5.04M-99.59%12.82K333.95%623.47K--623.47K57,197.26%3.1M94.42%143.67K
Prepaid assets 59.18%41.53K59.18%41.53K50.60%49.99K3.63%26.09K3.63%26.09K3.87%33.19K-4.27%25.18K--25.18K-27.06%31.95K-2.43%26.3K
-Available for sale securities --17.23M--17.23M15.55%13.84M----------11.98M----------------
Other assets 0.00%1890.00%1891,400.53%2.84K0.00%1890.00%189-91.42%189-97.17%189--189-97.26%2.2K-92.73%6.67K
Total assets 14.40%460.58M14.40%460.58M2.14%441.95M-2.92%402.6M-2.92%402.6M-3.51%432.69M-22.36%414.73M--414.73M-10.91%448.41M10.33%534.19M
Liabilities
Payables --470.23K--470.23K-92.87%665.12K---------22.36%9.33M86.11%16.19M--16.19M27,169.06%12.02M62,297.12%8.7M
-Accounts payable --1.79K--1.79K--229.3K--------------5.1M--5.1M7,935.07%3.54M----
-Other payable --468.44K--468.44K-95.33%435.82K--------10.07%9.33M27.49%11.09M--11.09M--8.48M62,297.12%8.7M
Derivative product liabilities --50.81K--50.81K--------------------------209.84K11,002.51%1.34M
Total liabilities 33.23%888.61K33.23%888.61K-91.24%879.91K-96.04%666.96K-96.04%666.96K-22.36%10.04M56.56%16.82M--16.82M1,891.35%12.94M1,705.34%10.75M
Shareholders'equity
Share capital 4.74%280.61K4.74%280.61K4.34%273.51K4.33%267.91K4.33%267.91K4.25%262.12K4.10%256.8K--256.8K3.56%251.44K3.29%246.68K
-common stock 4.74%280.61K4.74%280.61K4.34%273.51K4.33%267.91K4.33%267.91K4.25%262.12K4.10%256.8K--256.8K3.56%251.44K3.29%246.68K
Paid-in capital 3.01%415.29M3.01%415.29M3.81%410.6M3.88%403.15M3.88%403.15M3.85%395.55M4.19%388.1M--388.1M4.57%380.89M4.54%372.49M
Retained earnings 3,079.17%44.13M3,079.17%44.13M12.52%30.19M-115.51%-1.48M-115.51%-1.48M-50.62%26.83M-93.66%9.55M--9.55M-60.68%54.34M18.63%150.7M
Total stockholders'equity 14.37%459.69M14.37%459.69M4.36%441.07M1.01%401.93M1.01%401.93M-2.95%422.65M-23.98%397.9M--397.9M-13.37%435.47M8.24%523.44M
Total equity 14.37%459.69M14.37%459.69M4.36%441.07M1.01%401.93M1.01%401.93M-2.95%422.65M-23.98%397.9M--397.9M-13.37%435.47M8.24%523.44M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion----Unqualified Opinion----Unqualified Opinion----Unqualified Opinion
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.